ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,021,902 | +31.7% | 342,699 | +27.7% | 0.00% | – |
Q2 2023 | $5,330,485 | -33.3% | 268,268 | -42.5% | 0.00% | – |
Q1 2023 | $7,990,494 | +57.5% | 466,462 | +80.0% | 0.00% | -100.0% |
Q4 2022 | $5,071,761 | +22.6% | 259,160 | +0.0% | 0.00% | – |
Q3 2022 | $4,136,000 | +32.6% | 259,153 | +14.4% | 0.00% | – |
Q2 2022 | $3,118,000 | -27.6% | 226,599 | -16.6% | 0.00% | – |
Q1 2022 | $4,309,000 | -54.0% | 271,664 | -36.7% | 0.00% | -100.0% |
Q4 2021 | $9,368,000 | -29.8% | 429,124 | -3.8% | 0.00% | 0.0% |
Q3 2021 | $13,337,000 | -46.1% | 446,218 | -20.2% | 0.00% | -50.0% |
Q2 2021 | $24,751,000 | -25.0% | 558,836 | -24.8% | 0.00% | -33.3% |
Q1 2021 | $32,986,000 | -27.2% | 743,436 | -10.1% | 0.00% | -25.0% |
Q4 2020 | $45,333,000 | +144.4% | 826,636 | +1.9% | 0.00% | +100.0% |
Q3 2020 | $18,547,000 | -11.5% | 811,336 | -18.9% | 0.00% | 0.0% |
Q2 2020 | $20,946,000 | +30.6% | 1,000,779 | -12.9% | 0.00% | 0.0% |
Q1 2020 | $16,037,000 | -44.7% | 1,149,587 | -9.7% | 0.00% | -33.3% |
Q4 2019 | $28,987,000 | +83.0% | 1,273,587 | -6.3% | 0.00% | +50.0% |
Q3 2019 | $15,842,000 | -22.3% | 1,359,787 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $20,397,000 | -20.6% | 1,359,787 | -7.2% | 0.00% | -33.3% |
Q1 2019 | $25,697,000 | +18.3% | 1,465,099 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $21,713,000 | -17.7% | 1,465,099 | +36.6% | 0.00% | 0.0% |
Q3 2018 | $26,398,000 | – | 1,072,199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |